These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20560192)

  • 1. FDA notifications. Rare complication with didanosine.
    AIDS Alert; 2010 Apr; 25(4):46-8. PubMed ID: 20560192
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. FDA grants approval for generic didanosine for oral solution.
    AIDS Alert; 2007 May; 22(5):58-9. PubMed ID: 17577960
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA approves pediatric efficacy supplement for didanosine capsules.
    AIDS Alert; 2008 Nov; 23(11):129. PubMed ID: 19043871
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
    AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA notifications. New labeling for Videx pediatric powder.
    AIDS Alert; 2009 Aug; 24(8):94-6. PubMed ID: 19705588
    [No Abstract]   [Full Text] [Related]  

  • 6. Adherence strategies. FDA approves ddI generic version.
    AIDS Alert; 2006 Nov; 21(11):131. PubMed ID: 17111491
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA notifications. FDA grants tentative approval to generic stavudine.
    AIDS Alert; 2006 Feb; 21(2):24. PubMed ID: 16562341
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA notifications. FDA grants tentative approval to generic Nevirapine.
    AIDS Alert; 2006 Feb; 21(2):23-4. PubMed ID: 16562340
    [No Abstract]   [Full Text] [Related]  

  • 9. Side effects. FDA issues warning about d4T and ddI during pregnancy.
    TreatmentUpdate; 2001; 12(8):6-7. PubMed ID: 12132441
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA notifications. FDA grants approval of generic lamivudine tablets.
    AIDS Alert; 2009 Dec; 24(12):142-3. PubMed ID: 20063478
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
    AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA notifications. Generic emtricitabine is approved by the FDA.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19222147
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Tentative approval for lamivudine.
    AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. FDA approved 3 generic formulations of stavudine.
    AIDS Alert; 2009 Feb; 24(2):21. PubMed ID: 19219951
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA notifications. Tentative approval granted for lamivudine/stavudine.
    AIDS Alert; 2008 Aug; 23(8):92-3. PubMed ID: 18727174
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA notifications. Tentative approval for generic nevirapine tablets.
    AIDS Alert; 2007 Oct; 22(10):118-9. PubMed ID: 18418905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.